[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371780-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371780-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-mitochondrial-dna-in-modulating-chemoresistance-in-esophageal-cancer-mechanistic-insights-and-therapeutic-potential","The Role of Mitochondrial DNA in Modulating Chemoresistance in Esophageal Cancer: Mechanistic Insights and Therapeutic Potential","","Chemotherapy remains a cornerstone in the treatment of esophageal cancer (EC), yet chemoresistance continues to undermine durable response and overall outcomes. Mitochondrial DNA (mtDNA) is presented as a key mediator linking mitochondrial metabolism, oxidative stress control, and apoptotic signaling. This review synthesizes how mtDNA mutations and copy number variations drive chemoresistance in EC, including effects on metabolic reprogramming, the Warburg effect, lipid metabolism, epithelial–mesenchymal transition, and mitochondrial bioenergetics.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-mitochondrial-dna-in-modulating-chemoresistance-in-esophageal-cancer-mechanistic-insights-and-therapeutic-potential/371780/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-mitochondrial-dna-in-modulating-chemoresistance-in-esophageal-cancer-mechanistic-insights-and-therapeutic-potential/371780.png","ImageObject",300,407,{"name":42,"@type":43},"Mimi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does mtDNA influence chemoresistance in esophageal cancer?","Question",{"text":63,"@type":64},"The review explains that mtDNA alterations affect cellular metabolism, oxidative stress regulation, and apoptotic pathways, which together contribute to chemotherapy resistance in esophageal cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which mtDNA changes are highlighted as drivers of chemoresistance?",{"text":68,"@type":64},"The document focuses on mtDNA mutations and copy number variations, emphasizing their roles in metabolic reprogramming and mitochondrial function.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic strategies targeting mitochondrial pathways are discussed?",{"text":72,"@type":64},"Recent approaches include mitochondrial pathway targeting agents such as metformin and mitoquinone, along with innovative methods like CRISPR/Cas9 gene editing.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371780,1790215981,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review  \nThe Role of Mitochondrial DNA in Modulating Chemoresistance in Esophageal Cancer: Mechanistic Insights and  \nTherapeutic Potential  \nKoji Tanaka 1, *, Yasunori Masuike 2, Yuto Kubo 3, Takashi Harino 4, Yukinori Kurokawa 1, Hidetoshi Eguchi 1 and Yuichiro Doki 1  \nAcademic Editor: Ladislav Andˇera  \nReceived: 21 June 2025  \nRevised: 28 July 2025  \nAccepted: 4 August 2025  \nPublished: 5 August 2025  \nCitation: Tanaka, K.; Masuike, Y.; Kubo, Y.; Harino, T.; Kurokawa, Y.; Eguchi, H.; Doki, Y. The Role of Mitochondrial DNA in Modulating Chemoresistance in Esophageal Cancer: Mechanistic Insights and Therapeutic Potential. Biomolecules 2025, 15, 1128. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/biom15081128](10.3390/biom15081128)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Departments of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan  \n2 Department of Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan  \n3 Department of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa 277-8577, Japan  \n4 Department of Surgery, Kansai Medical University, Hirakata 573-1191, Japan  \n* Correspondence: [ktanaka@gesurg.med.osaka-u.ac.jp](ktanaka@gesurg.med.osaka-u.ac.jp); Tel.: +81-6-6879-3251; Fax: +81-6-6879-3259  \nAbstract  \nChemotherapy remains a cornerstone in the treatment of esophageal cancer (EC), yet chemoresistance remains a critical challenge, leading to poor outcomes and limited therapeutic success. Mitochondrial DNA (mtDNA) has emerged as a pivotal player in mediating these responses, influencing cellular metabolism, oxidative stress regulation, and apoptotic pathways. This review provides a comprehensive overview of the mechanisms by which mtDNA alterations, including mutations and copy number variations, drive chemoresistance in EC. Specific focus is given to the role of mtDNA in metabolic reprogramming, including its contribution to the Warburg effect and lipid metabolism, as well as its impact on epithelial–mesenchymal transition (EMT) and mitochondrial bioenergetics. Recent advances in targeting mitochondrial pathways through novel therapeutic agents, such as metformin and mitoquinone, and innovative approaches like CRISPR/Cas9 gene editing, are also discussed. These interventions highlight the potential for overcoming chemoresistance and improving patient outcomes. By integrating mitochondrial diagnostics with personalized treatment strategies, we propose a roadmap for future research that bridges basic mitochondrial biology with translational applications in oncology. The insights offered in this review emphasize the critical need for continued exploration of mtDNA-targeted therapies to address the unmet needs in EC management and other diseases associated with mitochondria.  \nKeywords: mitochondrial DNA; esophageal cancer; chemotherapy resistance; mtDNA mutations; oxidative phosphorylation; mitochondrial-targeted therapy  \n1. Introduction  \nEsophageal cancer (EC) is a leading cause of cancer-related mortality, ranking as the eighth most common malignancy globally [1–4] . It is characterized by its aggressive nature, late-stage diagnosis, and poor overall prognosis, with a five-year survival rate below 20% for advanced cases [5–7] . While multimodal treatment strategies, including surgery, radiation, and chemotherapy, have improved outcomes, the clinical management of advancedEC remains challenging [8] . Chemoresistance, defined as the failure to respond to chemotherapeutic regimens, represents one of the most significant barriers to effective treatment and  \ncontributes to disease progression and recurrence. Recent epidemiologic","cbCaipeZh7sYb8co","https://ap.wps.com/l/cbCaipeZh7sYb8co","pdf",1226492,13,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"How does mtDNA influence chemoresistance in esophageal cancer?\",\"answer\":\"The review explains that mtDNA alterations affect cellular metabolism, oxidative stress regulation, and apoptotic pathways, which together contribute to chemotherapy resistance in esophageal cancer.\"},{\"question\":\"Which mtDNA changes are highlighted as drivers of chemoresistance?\",\"answer\":\"The document focuses on mtDNA mutations and copy number variations, emphasizing their roles in metabolic reprogramming and mitochondrial function.\"},{\"question\":\"What therapeutic strategies targeting mitochondrial pathways are discussed?\",\"answer\":\"Recent approaches include mitochondrial pathway targeting agents such as metformin and mitoquinone, along with innovative methods like CRISPR/Cas9 gene editing.\"}]","The Role of Mitochondrial DNA in Modulating Chemoresistance in Esophageal Cancer: Mechanistic Insights and Therapeutic Potential | PDF",1790192851,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1886ac0ff9b5925298f8287a4198e21.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8dd64ba6b0b0d02ed1c33f8352d8778e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29b4e8a0e1849940b0570654675e3f4d.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27f7e22b1c3e9cf7463c430115fe7c93.webp",980,1385]